-
Thematic Analysis
State of the Biopharmaceutical Industry in 2024 – Thematic Intelligence
Accessing in-depth insights from the ‘State of the Biopharmaceutical Industry’ report will help you in: Examining the current attitudes of business leaders toward the emerging trends impacting the biopharmaceutical industry in the next 12 months. Benchmarking the impact of major themes on the biopharmaceutical industry in 2024, including emerging technologies, regulatory trends, macroeconomic trends, and industry trends. Identifying the most impactful anticipated regulatory approvals and drug launches in the industry in 2024, learning about top-selling drugs (2023 vs 2024), and obtaining...
-
Track & Monitor
Cybersecurity in Healthcare: Drug Delivery Device Security
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the healthcare industry’s Drug Delivery Device Security segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered...
-
Company Profile
Pear Therapeutics Inc – Company Profile
Pear Therapeutics Inc (Pear Therapeutics) develops software-based prescription digital therapeutics for the treatment of severe medical conditions and diseases. The company’s lead product candidate is reSET for treating substance use disorder. Its product pipeline includes reSET-O for the treatment of opioid use disorder (OUD) in conjunction with opioid replacement therapy; Somryst against chronic insomnia; PEAR-004 targeting schizophrenia; and PEAR-006 for treating multiple sclerosis. The company’s PDT platform is developing therapies targeting Alzheimer's disease, autoimmune disorders, depression, gastrointestinal disorders, migraine, and...
Add to Basket -
Product Insights
NewPear Therapeutics Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Pear Therapeutics Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Pear Therapeutics Inc (Pear Therapeutics) develops software-based prescription digital therapeutics for the treatment of severe medical conditions and diseases. The company’s lead product candidate is reSET for treating substance use disorder. Its product pipeline includes reSET-O for the treatment of opioid use disorder (OUD) in conjunction with opioid replacement therapy; Somryst against chronic insomnia; PEAR-004 targeting schizophrenia; and PEAR-006...
-
Track & Monitor
Artificial Intelligence in Healthcare: Drug Delivery Device Security
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the healthcare industry’s Drug Delivery Device Security segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered...
-
Track & Monitor
Cloud in Healthcare: Drug Delivery Device Security
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the healthcare industry’s Drug Delivery Device Security segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered...
-
Track & Monitor
Internet of Things in Healthcare: Drug Delivery Device Security
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the healthcare industry’s Drug Delivery Device Security segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered...
-
Track & Monitor
Cybersecurity in Medical Devices: Data Masking for Privacy
Innovations in medical devices industry is relentless, making it hard to stay-on top of the dynamically evolving industry landscape and in early identification of profound shifts posing high risk of being disrupted if detected too late. GlobalData's coherent data-driven approach, using multiple forward-looking alternative datasets, empowers clients by decoding in advance the disruptive innovations in medical devices industry. Using patent data, GlobalData's proprietary industry innovation s-curve identifies specific innovation areas and their stage of evolution, i.e., whether they are emerging,...
-
Track & Monitor
Artificial Intelligence in Healthcare: Speech Emotion Recognition and Analysis
Innovations in healthcare industry is relentless, making it hard to stay-on top of the dynamically evolving industry landscape and in early identification of profound shifts posing high risk of being disrupted if detected too late. GlobalData's coherent data-driven approach, using multiple forward-looking alternative datasets, empowers clients by decoding in advance the disruptive innovations in healthcare industry. Using patent data, GlobalData's proprietary industry innovation s-curve identifies specific innovation areas and their stage of evolution, i.e., whether they are emerging, accelerating or...
-
Track & Monitor
Internet of Things in Healthcare: Speech Emotion Recognition and Analysis
Innovations in healthcare industry is relentless, making it hard to stay-on top of the dynamically evolving industry landscape and in early identification of profound shifts posing high risk of being disrupted if detected too late. GlobalData's coherent data-driven approach, using multiple forward-looking alternative datasets, empowers clients by decoding in advance the disruptive innovations in healthcare industry. Using patent data, GlobalData's proprietary industry innovation s-curve identifies specific innovation areas and their stage of evolution, i.e., whether they are emerging, accelerating or...